Plaintiffs win $502M verdict against Johnson & Johnson over hip device — 5 things to know

Five plaintiffs have won a $502 million verdict against Johnson & Johnson in a bellwether trial concerning the company’s DePuy Pinnacle metal-on-metal hip replacement devices.

Advertisement

Here are five things to know:

 

1. The jury verdict for $142 million compensatory and $360 million punitive damages followed 37 days of testimony.

 

2. The trial, which consolidated cases involving five separate plaintiffs who are Texas residents, began Jan. 8.

 

3. The lawsuits, including those of more than 7,000 plaintiffs nationwide in the multidistrict litigation, claim that the DePuy implants were defective and caused metal debris to enter into patients’ bloodstreams. This allegedly caused severe injuries and sometimes led to revision surgery.

 

4. Plaintiffs’ attorneys also claim to have discovered several instances in which physicians lied in medical clinical testing of the devices and forged consent forms for patients who were using the product to lie about the results the patients experienced with the product.

 

5. The DePuy Pinnacle hip implants have not been recalled.

 

More articles on devices and implants:
Touch Surgery, Zimmer Biomet launch Oxford Partial Knee training — 4 points
Life Spine sales jump 45% in 6 months: 5 key notes
SpineGuard, OrthoPediatrics collaborate on pediatric spine technology: 5 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.